General Information of the Compound
| Compound ID |
CP0037451
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
1,1',1'',1'''-[disulfanediylbis(carbonothioylnitrilo)]tetraethane
Show/Hide
|
||||||||||||||||||
| Synonyms |
Abstenisil
Abstinil
Abstinyl
Accel TET
Accel TET-R
Akrochem TETD
Alcophobin
Alk-aubs
Ancazide ET
Antab use
Antabus
Antabus (TN)
Antabuse
Antabuse (TN)
Antadix
Antaenyl
Antaethan
Antaethyl
Antaetil
Antalcol
Antetan
Antethyl
Antetil
Anteyl
Anthethyl
Anti-ethyl
Antiaethan
Anticol
Antietanol
Antiethanol
Antietil
Antikol
Antivitium
Antivitium (Spain)
Aversan
Averzan
Bonibal
Contralin
Contrapot
Cronetal
Dicupral
Disetil
Disulfan
Disulfiram
Disulfirame
Disulfirame [DCIT]
Disulfiramo
Disulfiramum
Disulfirm
Disulfram
Disulfuram
Disulphuram
Dupon 4472
ENT 27,340
Ekagom DTET
Ekagom TEDS
Ekagom TETDS
Ekaland TETD
Ephorran
Espenal
Esperal
Esperal [France]
Eta bus
Etabus
Ethyl Thiram
Ethyl Thiudad
Ethyl Thiurad
Ethyl Tuads Rodform
Ethyl Tuex
Ethyl tuads
Ethyldithiourame
Ethyldithiurame
Etyl Tuex
Exhoran
Exhorran
Gababentin
Hoca
Krotenal
Nocbin
Nocceler
Nocceler TET
Nocceler TET-G
Noxal
Noxal (VAN)
Perkacit TETD
Perkait TETD
Refusal
Ro-Sulfram-500 (USA)
Ro-sulfiram
Robac TET
Sanceler TET
Sanceler TET-G
Soxinol TET
Stopaethyl
Stopethyl
Stopety
Stopetyl
T 1132
TATD
TETD
THIOCID
TTD
TTS
TTS x
Tenurid
Tenutex
Tet raethylthiuram
Tetidis
Tetradin
Tetradine
Tetraethylthiuram
Tetraetil
Teturam
Teturamin
Thireranide
Thiuram E
Thiuranide
Tillram
Tiuram
Tuads, ethyl
Usaf B-33
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C10H20N2S4
|
||||||||||||||||||
| Molecular Weight |
296.552
|
||||||||||||||||||
| Canonical SMILES |
CCN(CC)C(=S)SSC(=S)N(CC)CC
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C10H20N2S4/c1-5-11(6-2)9(13)15-16-10(14)12(7-3)8-4/h5-8H2,1-4H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
AUZONCFQVSMFAP-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
97-77-8
11078-22-1
155-01-1
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00918, Amine oxidase [flavin-containing] A
Protein ID: PT01002, Cytochrome P450 1A2
Protein ID: PT06109, Geminin
Protein ID: PT02997, Isocitrate dehydrogenase [NADP] cytoplasmic
Protein ID: PT04868, Lysyl oxidase homolog 2
Protein ID: PT05466, Lysyl oxidase homolog 3
Protein ID: PT03356, NACHT, LRR and PYD domains-containing protein 3
Protein ID: PT05764, Protein-lysine 6-oxidase
Protein ID: PT01065, Serine/threonine-protein kinase mTOR
Clinical Information about the Compound
Drug 1 ( Disulfiram )
| Drug Name | Disulfiram | ||
|---|---|---|---|
| Company | Odyssey Pharmaceuticals | ||
| Indication | |||
| Target(s) | |||